Intelligence & Thought Leadership

Aesis Group

Creating Value in the Life Sciences

Companies	Biopharma topics	Device topics	Cross-Industry Topics
Abbott	AIDS	Artificial heart	Biotech Business Models
Abiomed	Biotechnology	Bioelectromagnetics	Clinical Trials
Amgen	Cancer	Cancer	Convergent Medical Technology
AstraZeneca	Cardiovascular	Cardiovascular	Ethics
Baxter	Convergent Medical Technology	Convergent Medical Technology	FDA Reform
Boston Scientific	Diabetes	Cosmetic implantables	Health impact tax
Bristol Myers Squibb	Diagnostics	GERD	Health policy
Eli Lilly	Erythropoietin	Drug-eluting stents	Incubators
GE Healthcare	Gene Therapy	Medical design	Innovation
Genzyme	Genomics	Minimally Invasive Surgery	Intellectual Property
GlaxoSmithKline	Personalized Medicine	Radiology	Life Sciences Accelerator
Guidant	Pharmaceuticals	Smart Devices	Medical Diplomacy
ImClone	Proteomics		Medicare
J and J	Stem Cells		Midwest
Medtronic	Targeted Therapy		Neurosciences
Merck	Theranostics		Orthopedics
Pfizer	Vioxx		Partnerships
Takeda			Private Equity
			Safety
			Venture Capital